tm logo

Monitor this mark

View On USPTO

LACRISEAL
Live/Registered
REGISTERED AND RENEWED

on 16 Feb 2023

Last Applicant/ Owned by

NORDIC PHARMA, INC.

1205 WESTLAKES DRIVE, SUITE 275

BERWYN

PA

19312

Serial Number

76697071 filed on 24th Apr 2009

Registration Number

4186941 registered on 07th Aug 2012

in the Principal Register

Correspondent Address

Anna Kurian Shaw

Anna Kurian Shaw

555 13th Street NW

Washington,DC 20004

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LACRISEAL

Medical devices, namely, viscous implant comprising of artificial materials for forming dissolvable occlusion of the canaliculi

Classification Information

Class [010]
Medical Instrument Products

Medical devices, namely, viscous implant comprising of artificial materials for forming dissolvable occlusion of the canaliculi

First Use Date in General

11th Jun 2012

First Use Date in Commerce

11th Jun 2012

Mark Details

Serial Number

No 76697071

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 762027.00003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
10th Apr 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04th Apr 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
04th Apr 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04th Apr 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04th Apr 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04th Apr 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
16th Feb 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16th Feb 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
16th Feb 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16th Feb 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED